XML 101 R102.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Financial Information (Parent Company Only) - Condensed Statements of Cash Flows (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net income $ 58,224,000 $ 44,546,000 $ 37,356,000
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 17,112,000 17,368,000 20,136,000
Write-down of equipment pending disposal 70 0 0
Deferred income tax expense (benefit) 8,762,000 2,405,000 (17,257,000)
Stock-based compensation expense 2,485,000 2,111,000 1,764,000
Tax benefits from stock-based compensation 360,000 204,000 239,000
Excess tax benefits from stock-based compensation (273,000) (124,000) (225,000)
Net cash provided by operating activities 135,822,000 143,101,000 109,258,000
Cash flows from investing activities:      
Net cash used in investing activities (141,079,000) (125,939,000) (387,511,000)
Cash flows from financing activities:      
Repayments of long-term debt (40,000) (302,000) (35,851,000)
Repayment of junior subordinated debentures held by subsidiary trusts (41,238,000) 0 0
Proceeds from issuance of common stock 1,911,000 385,000 167,400,000
Common stock issuance costs 0 0 (13,597,000)
Excess tax benefits from stock-based compensation 273,000 124,000 225,000
Purchase and retirement of common stock (263,000) (248,000) (3,699,000)
Dividends paid to common stockholders (26,208,000) (19,233,000) (17,905,000)
Dividends paid to preferred stockholders (3,300,000) (3,422,000) (3,422,000)
Net cash provided by (used in) financing activities 334,142,000 (230,333,000) 340,389,000
Net change in cash and cash equivalents 328,885,000 (213,171,000) 62,136,000
Cash and cash equivalents at beginning of year 472,447,000 685,618,000 623,482,000
Cash and cash equivalents at end of year 801,332,000 472,447,000 685,618,000
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]      
Transfer of preferred stock pending redemption from equity to liability 50,000,000    
Transfered accrued liabilities to common stock in conjunction with the vesting of liability-classified non-vested stock awards   216,000 59,000
Parent Company
     
Cash flows from operating activities:      
Net income 58,224,000 44,546,000 37,356,000
Adjustments to reconcile net income to cash provided by operating activities:      
Undistributed earnings of subsidiaries (28,914,000) (25,444,000) (32,226,000)
Stock-based compensation expense 2,485,000 2,111,000 1,764,000
Tax benefits from stock-based compensation 360,000 204,000 239,000
Excess tax benefits from stock-based compensation (273,000) (124,000) (225,000)
Other, net 3,327,000 2,600,000 (4,325,000)
Net cash provided by operating activities 35,209,000 23,893,000 2,583,000
Cash flows from investing activities:      
Capitalization of subsidiaries 0 0 (130,000)
Capital expenditures, net of sales 1,000 (3,000) 0
Net cash used in investing activities 1,000 (3,000) (130,000)
Cash flows from financing activities:      
Net (decrease) increase in advances from nonbank subsidiaries (2,838,000) (2,913,000) 5,002,000
Repayments of long-term debt 0 0 (33,929,000)
Repayment of junior subordinated debentures held by subsidiary trusts (41,238,000) 0 0
Proceeds from issuance of common stock 1,911,000 385,000 167,400,000
Common stock issuance costs 0 0 (13,597,000)
Excess tax benefits from stock-based compensation 273,000 124,000 225,000
Purchase and retirement of common stock (263,000) (248,000) (3,699,000)
Dividends paid to common stockholders (26,208,000) (19,233,000) (17,905,000)
Dividends paid to preferred stockholders (3,300,000) (3,422,000) (3,422,000)
Net cash provided by (used in) financing activities (71,663,000) (25,307,000) 100,075,000
Net change in cash and cash equivalents (36,453,000) (1,417,000) 102,528,000
Cash and cash equivalents at beginning of year 131,860,000 133,277,000 30,749,000
Cash and cash equivalents at end of year 95,407,000 131,860,000 133,277,000
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]      
Transfer of preferred stock pending redemption from equity to liability $ 50,000,000